4.7 Review

Unlocking the Potential of Stroke Blood Biomarkers: Early Diagnosis, Ischemic vs. Haemorrhagic Differentiation and Haemorrhagic Transformation Risk: A Comprehensive Review

Related references

Note: Only part of the references are listed.
Article Neurosciences

Serum Interleukin-33 is a Novel Predictive Biomarker of Hemorrhage Transformation and Outcome in Acute Ischemic Stroke

Zhenlei Chen et al.

Summary: This study demonstrates that serum IL-33 concentration is associated with HT in AIS, with IL-33 concentration <= 67.66 ng/L serving as an independent predictor of HT in AIS. Patients with HT have a higher risk of unfavorable outcome compared to those without HT.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2021)

Review Clinical Neurology

Hemorrhagic Transformation in Ischemic Stroke and the Role of Inflammation

Elena Spronk et al.

Summary: Hemorrhagic transformation is a common complication in acute ischemic stroke patients, with factors such as stroke severity, reperfusion therapy, hypertension, hyperglycemia, and age increasing the risk. Inflammation and the immune system play important roles in BBB disruption and HT, with therapies targeting these pathways being potential strategies to reduce the risk of HT.

FRONTIERS IN NEUROLOGY (2021)

Review Clinical Neurology

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association

Dawn O. Kleindorfer et al.

Summary: Additional digital content is available in the text.

STROKE (2021)

Review Clinical Neurology

Scalable Bio Marker Combinations for Early Stroke Diagnosis: A Systematic Review

Saiyet de la C. Baez et al.

Summary: The systematic review highlights the potential of utilizing blood-based panels of protein biomarkers to enhance the diagnosis of stroke. Brain-specific markers such as NR2 peptide and glial fibrillary acidic protein (GFAP) are shown to be related to stroke. Further research is needed to validate and introduce these novel biomarker combinations for more effective stroke diagnosis and prevention.

FRONTIERS IN NEUROLOGY (2021)

Review Biochemistry & Molecular Biology

The Need for New Biomarkers to Assist with Stroke Prevention and Prediction of Post-Stroke Therapy Based on Plasma-Derived Extracellular Vesicles

Mircea Popescu Driga et al.

Summary: Developing neurorestorative therapies for stroke is crucial, as the risk of stroke doubles with each decade after the age of 55. Extracellular vesicles shed by brain cells could provide insights into molecular and cellular events in the damaged brain area. Utilizing exosomes-mediated interactions between brain cells may help predict the individual course of the disease and introduce specific preventive or therapeutic strategies.

BIOMEDICINES (2021)

Article Biochemistry & Molecular Biology

Adrenomedullin Is a Diagnostic and Prognostic Biomarker for Acute Intracerebral Hemorrhage

Francisco J. Julian-Villaverde et al.

Summary: Adrenomedullin (AM) may serve as a new diagnostic and prognostic biomarker for hemorrhagic stroke, identifying it as a positive mediator for the resolution of the condition. Levels of AM were consistently higher in stroke patients compared to healthy controls, with potential diagnostic value, while patients with favorable outcomes showed specific patterns of AM level changes over time. Additionally, lower levels of nitrogen oxide compounds were observed in stroke patients at certain time points.

CURRENT ISSUES IN MOLECULAR BIOLOGY (2021)

Article Clinical Neurology

European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke

Eivind Berge et al.

Summary: Intravenous thrombolysis is the approved systemic reperfusion treatment for acute ischaemic stroke patients, with the ESO guidelines providing evidence-based recommendations. The guidelines highlight the importance of timely thrombolysis within 4.5 hours for improving functional outcomes, and recommend its use for specific patient subgroups such as those waking from sleep.

EUROPEAN STROKE JOURNAL (2021)

Review Biochemistry & Molecular Biology

Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives

Diji Kuriakose et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Cardiac & Cardiovascular Systems

Time is brain: timing of revascularization of brain arteries in stroke

Angela Risitano et al.

EUROPEAN HEART JOURNAL SUPPLEMENTS (2020)

Review Neurosciences

Blood Biomarkers for Stroke Diagnosis and Management

Joseph Kamtchum-Tatuene et al.

NEUROMOLECULAR MEDICINE (2019)

Article Clinical Neurology

New biomarker for acute ischaemic stroke: plasma glycogen phosphorylase isoenzyme BB

Kwang-Yeol Park et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)

Article Clinical Neurology

Glial Fibrillary Acidic Protein for Prehospital Diagnosis of Intracerebral Hemorrhage

Michal Rozanski et al.

CEREBROVASCULAR DISEASES (2017)

Article Biochemistry & Molecular Biology

Stroke biomarkers in clinical practice: A critical appraisal

Geelyn J. L. Ng et al.

NEUROCHEMISTRY INTERNATIONAL (2017)

Article Clinical Neurology

Blood Biomarkers for the Early Diagnosis of Stroke The Stroke-Chip Study

Alejandro Bustamante et al.

STROKE (2017)

Article Medical Laboratory Technology

Comparison of miR-124-3p and miR-16 for early diagnosis of hemorrhagic and ischemic stroke

Ling Yan Leung et al.

CLINICA CHIMICA ACTA (2014)

Review Endocrinology & Metabolism

Hemorrhagic transformation after ischemic stroke in animals and humans

Glen C. Jickling et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)

Article Neurosciences

A Blood-based Biomarker Panel to Detect Acute Stroke

Richa Sharma et al.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2014)

Article Neurosciences

The Second Elevation of Neuron-Specific Enolase Peak after Ischemic Stroke Is Associated with Hemorrhagic Transformation

Bum Joon Kim et al.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2014)

Review Clinical Neurology

Magnetic Resonance Imaging in Acute Ischemic Stroke Treatment

Bum Joon Kim et al.

JOURNAL OF STROKE (2014)

Review Medicine, Research & Experimental

Functions of S100 Proteins

R. Donato et al.

CURRENT MOLECULAR MEDICINE (2013)

Article Medicine, General & Internal

Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke

Jeffrey L. Saver et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

Article Biochemical Research Methods

Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: The S100B/RAGE pathway

Joan Montaner et al.

JOURNAL OF PROTEOMICS (2012)

Article Multidisciplinary Sciences

Diagnostic Potential of the NMDA Receptor Peptide Assay for Acute Ischemic Stroke

Svetlana A. Dambinova et al.

PLOS ONE (2012)

Review Immunology

Interleukin-33 and the function of innate lymphoid cells

Ananda S. Mirchandani et al.

TRENDS IN IMMUNOLOGY (2012)

Article Clinical Neurology

Antithrombin III associated with fibrinogen predicts the risk of cerebral ischemic stroke

Ran Meng et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2011)

Article Clinical Neurology

N-terminal probrain natriuretic peptide as a biomarker of cardioembolic stroke

Ana Catarina Fonseca et al.

INTERNATIONAL JOURNAL OF STROKE (2011)

Article Clinical Neurology

1H-NMR-Based Metabolomics Study of Cerebral Infarction

Jee Youn Jung et al.

STROKE (2011)

Article Medical Laboratory Technology

Plasma MicroRNAs as Sensitive and Specific Biomarkers of Tissue Injury

Omar F. Laterza et al.

CLINICAL CHEMISTRY (2009)

Article Medicine, General & Internal

Sensitive Troponin I Assay in Early Diagnosis of Acute Myocardial Infarction.

Till Keller et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Clinical Neurology

Apoptotic Mechanisms After Cerebral Ischemia

Brad R. S. Broughton et al.

STROKE (2009)

Article Emergency Medicine

Ischemia-modified albumin levels in cerebrovascular accidents

Abdulkadir Gunduz et al.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2008)

Review Neurosciences

Blood-brain barrier tight junction permeability and ischemic stroke

Karin E. Sandoval et al.

NEUROBIOLOGY OF DISEASE (2008)

Article Medicine, General & Internal

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

Werner Hacke et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Clinical Neurology

Ischemia-modified albumin in acute stroke

Halim Abboud et al.

CEREBROVASCULAR DISEASES (2007)

Article Clinical Neurology

Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke

C Foerch et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)

Article Clinical Neurology

Time is brain - Quantified

JL Saver

STROKE (2006)

Article Medical Laboratory Technology

PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke

L Allard et al.

CLINICAL CHEMISTRY (2005)

Article Multidisciplinary Sciences

The functions of animal microRNAs

V Ambros

NATURE (2004)

Article Biochemical Research Methods

Fatty acid binding protein as a serum marker for the early diagnosis of stroke - A pilot study

CG Zimmermann-Ivol et al.

MOLECULAR & CELLULAR PROTEOMICS (2004)

Article Endocrinology & Metabolism

Molecular characterization of prostatic small-cell neuroendocrine carcinoma

N Clegg et al.

PROSTATE (2003)

Review Biochemistry & Molecular Biology

The TNF and TNF receptor superfamilies: Integrating mammalian biology

RM Locksley et al.